Novosti
Khirurgii

 This journal is
indexed in Scopus
journal cover
android icon Android Applicaion

Year 2013 Vol. 21 No 1

GENERAL AND SPECIAL SURGERY

V.I. RUSIN1, Ê.Å. RUMJANTSEV1, I.I. KOPOLOVEC1, I.B. KRAVCHUK 2

IMMEDIATE TREATMENT RESULTS OF BLEEDING FROM ESOPHAGEAL VARICES IN PATIENTS WITH B-CLASS LIVER CIRRHOSIS

SHEE “Uzhgorod National Universitó”1,
Transcarpatian Regional Clinical Hospital named after Andrey Novak2,
The Ukraine

Objectives. To evaluate the effectiveness of the treatment strategy of bleeding from the esophageal varices in patients with B-class liver cirrhosis according to Child-Pugh criteria.
Methods. 67 patients with B-class cirrhosis and bleeding from esophageal varices were included in the study. The endoscopic sclerotherapy was used to stop bleeding and in case of its ineffectiveness – the Blakemore tube was applied. Vasoactive therapy with octreotide or terlipressin, volumic resuscitation, antibiotics, solutions of aminoacids, proton pump inhibitors intravenously, menadione intramuscularly, lactulose appeared to be the components of the conservative treatment. Hepatic encephalopathy (I-II degree) was treated conservatively and albumin peritoneal dialysis was performed at III-IV degree.
Results. Endoscopic sclerotherapy stopped bleeding immediately in 53 (79%) of 67 patients. Blakemore tube was applied in the remaining 14 patients (21%). In 13 (26%) patients out of 53 endoscopic sclerotherapy was primary effective, recurrence of bleeding occurred within the first 5 days. In 9 of them it was stopped with the repeated session of endoscopic sclerotherapy, in 4 – with Blakemore tube. 5 (9,4%) patients died due to progression of the liver failure. Mortality calculated on the number of recurrences made up 38,5%. Recurrence took place in 8 (57,1%) out of 14 patients with Blakemore tube used initially. In 6 of them bleeding was stopped by the repeated endoscopic sclerotherapy. 8 (57,1%) patients died. Mortality calculated in patients with recurrences composed 100%. Mortality in the subgroup of the conservative treatment of encephalopathy made up 18%, in the case of the application of albumin peritoneal dialysis – 23,5%.
Conclusions. Endoscopic sclerotherapy is considered to be an effective method of bleeding treatment (an efficiency of 79% in primary haemorrhage stopping and 71% – at recurrence) with a moderate number of recurrences – 26% and a low mortality – 9,4%. Albumin peritoneal dialysis is considered to be a safe and effective treatment for hepatic encephalopathy of III-IV degree (23,5% mortality), which was not significantly different from that of patients with I-II degree.

Keywords: liver cirrhosis, esophageal varicose veins, bleeding, hepatic encephalopathy, endoscopic sclerotherapy, albumin peritoneal dialysis
p. 36 – 45 of the original issue
References
  1. Zviagintseva TD, Glushchenko SV. Khronicheskie diffuznye zabolevaniia pecheni: patogeneticheskie podkhody k lecheniiu [Chronic diffuse liver disease: pathogenetic approaches to treatment]. Zdorov’ia Ukra¿ni. 2010;(1):46–47.
  2. Dekompensovanii tsiroz pech³nki [Decompensated cirrhosis of liver]. Rusin V. ²., Siplivii V. O., Rusin AV, Beresnºv OV, Rumiantsev Kª. Uzhgorod, Ukraine: VETA-Zakarpattia; 2006. 232 p.
  3. Portal'naia gipertenziia i ee oslozhneniia [Portal hypertension and its complications]. Boiko VV, Nikishaev VI, Rusin VI, Boiko VV (red). Khar'kov, Ukraina: Martiniak, 2008. 335 p.
  4. De Franchis R. Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2010;6:1010–16.
  5. Sass DA, Chopra KB. Portal hypertension and variceal hemorrhage. Med Clin North Am. 2009 Jul;93(4):837–53, vii-viii. Review.
  6. Samonakis DN, Triantos CK, Thalheimer U, Patch DW, Burroughs AK. Management of portal hypertension. Postgrad Med J. 2004 Nov;80(949):634–41.
  7. Yan BM, Lee SS. Emergency management of bleeding esophageal varices: drugs, bands or sleep? Can J Gastroenterol. 2006 Mar;20(3):165–70.
  8. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007 Sep;46(3):922–38.
  9. Sanyal AJ, Bosch J, Blei A, Arroyo V. Portal hypertension and its complications. Gastroenterology. 2008 May;134(6):1715–28.
  10. Sovremennye dèagnostècheskèe è lechebnye podhody k pechenochnoj nedostatochnostè [Current diagnostic and therapeutic approaches to liver failure]. Rusèn VÈ, Avdeev VV, Rumjancev KE, Sirchak JeS, Maljar MN. Uzhgorod, Ukraèna: Karpaty; 2011. 360 p.
Address for correspondence:
88018, Ukraina, g. Uzhgorod, ul. Pobedy, d. 22, Zakarpatskaia oblastnaia klinicheskaia bol'nitsa im. A. Novaka, kafedra khirurgicheskikh boleznei meditsinskogo fakul'teta GVUZ «Uzhgorodskii natsional'nyi universitet»,
e-mail: rusinkafedra@gmail.com,
Rusin Vasilii Ivanovich
Information about the authors:
Rusin V.I. MD, professor, head of the surgical diseases chair of the medical faculty of SHEE “Uzhgorod National University”.
Rumjantsev K.E. PhD, associate professor of the surgical diseases chair of the medical faculty of SHEE “Uzhgorod National University”.
Kopolovec I.I. A post-graduate student of the surgical diseases chair of the medical faculty of SHEE “Uzhgorod National University”.
Kravchuk I.B. Endoscopist of Transcarpatian regional clinical hospital named after Andrey Novak.
Contacts | ©Vitebsk State Medical University, 2007-2023